FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2996804986> ?p ?o ?g. }

• W2996804986 endingPage "61" @default.
• W2996804986 startingPage "55" @default.
• W2996804986 abstract "BACKGROUND: Diabetes mellitus type 2 (T2DM) is associated with impaired glucose metabolism and peripheral insulin resistance, which is accompanied by an high risk of cardiovascular disease (CVD) and nephropathy. Metabolic syndrome and T2DM are accompanied by renin-angiotensin system (RAS) activation, which is also associated with increased risk of CVD and kidney damage. Obesity lead to a wide range of pathophysiological changes, that stimulate cardiac fibrosis, and various fibrosis processes initiation, including activation of transforming growth factor β (TGF-β). AIMS: To determine activity of angiotensin II (Ang II) and TGF-β in patients with obesity and T2DM and their association with heart and kidney damage. MATERIALS AND METHODS: Ang II and TGF-β were identified in the peripheral blood of 66 obese patients aged 48-65 years. The first group included 21 patients with coronary heart disease (CHD) and T2DM; The second group included 22 patients with T2DM and excluded CHD; The third group – 20 patients with normal glucose metabolism and excluded CHD. RESULTS: The values of TGF-β in the 1st group (patients with CHD) were statistically lower than in the group of metabolically healthy obesity (p=0.021). Patients who received DPP-4 inhibitors had a lower Ang II level compared to patients with other hypoglycemic therapy (p=0.005). TGF-β positively correlated with glomerular filtration rate (eGFR) in all patients (r=-0.414, p=0.006). TGF-β negatively correlated with the degree of internal carotid artery stenosis in patients of the 2nd group (r=-0.42, p=0.09) and LDL-cholesterol in all patients (r=-0.426, p=0.038). CONCLUSIONS: TGF-β negatively correlated with the factors that contribute to CVD progression. TGF-β correlated with pathological angiogenesis and changes in normal cardiac geometry in obesity, T2DM and CHD. DPP-4 inhibitors can improve the cardiovascular prognosis in this group of patients by affecting Ang II level. Low levels of TGF-β were associated with higher cardiovascular risk and were commonly found in patients with more severe nephropathy." @default.
• W2996804986 created "2020-01-10" @default.
• W2996804986 creator A5011373602 @default.
• W2996804986 creator A5029852837 @default.
• W2996804986 creator A5031749331 @default.
• W2996804986 creator A5031816886 @default.
• W2996804986 creator A5057396034 @default.
• W2996804986 creator A5060918913 @default.
• W2996804986 date "2019-12-21" @default.
• W2996804986 modified "2023-09-27" @default.
• W2996804986 title "Влияние ангиотензина II и трансформирующего фактора роста β на сердечно-сосудистые заболевания и поражение почек у пациентов с сахарным диабетом 2 типа" @default.
• W2996804986 doi "https://doi.org/10.14341/omet10346-9271" @default.
• W2996804986 hasPublicationYear "2019" @default.
• W2996804986 type Work @default.
• W2996804986 sameAs 2996804986 @default.
• W2996804986 citedByCount "0" @default.
• W2996804986 crossrefType "journal-article" @default.
• W2996804986 hasAuthorship W2996804986A5011373602 @default.
• W2996804986 hasAuthorship W2996804986A5029852837 @default.
• W2996804986 hasAuthorship W2996804986A5031749331 @default.
• W2996804986 hasAuthorship W2996804986A5031816886 @default.
• W2996804986 hasAuthorship W2996804986A5057396034 @default.
• W2996804986 hasAuthorship W2996804986A5060918913 @default.
• W2996804986 hasConcept C126322002 @default.
• W2996804986 hasConcept C134018914 @default.
• W2996804986 hasConcept C159641895 @default.
• W2996804986 hasConcept C164705383 @default.
• W2996804986 hasConcept C2777391703 @default.
• W2996804986 hasConcept C2779922275 @default.
• W2996804986 hasConcept C2780091579 @default.
• W2996804986 hasConcept C2781184683 @default.
• W2996804986 hasConcept C50440223 @default.
• W2996804986 hasConcept C511355011 @default.
• W2996804986 hasConcept C555293320 @default.
• W2996804986 hasConcept C71924100 @default.
• W2996804986 hasConceptScore W2996804986C126322002 @default.
• W2996804986 hasConceptScore W2996804986C134018914 @default.
• W2996804986 hasConceptScore W2996804986C159641895 @default.
• W2996804986 hasConceptScore W2996804986C164705383 @default.
• W2996804986 hasConceptScore W2996804986C2777391703 @default.
• W2996804986 hasConceptScore W2996804986C2779922275 @default.
• W2996804986 hasConceptScore W2996804986C2780091579 @default.
• W2996804986 hasConceptScore W2996804986C2781184683 @default.
• W2996804986 hasConceptScore W2996804986C50440223 @default.
• W2996804986 hasConceptScore W2996804986C511355011 @default.
• W2996804986 hasConceptScore W2996804986C555293320 @default.
• W2996804986 hasConceptScore W2996804986C71924100 @default.
• W2996804986 hasIssue "3" @default.
• W2996804986 hasLocation W29968049861 @default.
• W2996804986 hasOpenAccess W2996804986 @default.
• W2996804986 hasPrimaryLocation W29968049861 @default.
• W2996804986 hasVolume "16" @default.
• W2996804986 isParatext "false" @default.
• W2996804986 isRetracted "false" @default.
• W2996804986 magId "2996804986" @default.
• W2996804986 workType "article" @default.